7109 POSTER DISCUSSION An Individualized Dose/Schedule Strategy for Sunitinib in Metastatic Renal Cell Cancer (mRCC) May Improve Progression Free Survival (PFS) – Correlation With Dynamic Microbubble Ultrasound (DCE-US) Data

✍ Scribed by Bjarnason, G.; Khalil, B.; Williams, R.; Hudson, J.M.; Lloyd, B.; Milot, L.M.; Atri, M.; Kiss, A.; Burns, P.

• Book ID: 123557768
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 44 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)72024-X